2026 ICD-10-CM Diagnosis Code C79.19Secondary malignant neoplasm of other urinary organs
ICD-10-CM Codes›C00–D49›C76-C80›C79
- Billable — Valid for Submission
- Chronic Condition
C79.19 is a billable ICD-10-CM diagnosis code for secondary malignant neoplasm of other urinary organs. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 656 through 658, 686 through 688. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Secondary malignancies.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Carcinoma of ureter
- Malignant tumor involving ureter by direct extension from bladder
- Malignant tumor involving urethra by direct extension from bladder
- Malignant tumor involving urethra by direct extension from prostate
- Metastatic malignant neoplasm to paraurethral glands
- Metastatic malignant neoplasm to ureter
- Metastatic malignant neoplasm to urethra
- Metastatic transitional cell carcinoma to left ureter
- Metastatic transitional cell carcinoma to upper urinary tract
- Metastatic transitional cell carcinoma to ureter
- Transitional cell carcinoma of left ureter
- Transitional cell carcinoma of ureter
- Ureter involved by direct extension of malignant neoplasm
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Table of NeoplasmsClinical
Anatomical sites in the Table of Neoplasms that reference this code family.
| Site | Malig. Primary | Malig. Secondary | Ca in situ | Benign | Uncertain | Unspec. |
|---|---|---|---|---|---|---|
| bulbourethral gland | C68.0 | C79.19 | D09.19 | D30.4 | D41.3 | D49.59 |
| Cowper's gland | C68.0 | C79.19 | D09.19 | D30.4 | D41.3 | D49.59 |
| paraurethral › gland | C68.1 | C79.19 | D09.19 | D30.8 | D41.8 | D49.59 |
| prostate (gland) › utricle | C68.0 | C79.19 | D09.19 | D30.4 | D41.3 | D49.59 |
| Skene's gland | C68.1 | C79.19 | D09.19 | D30.8 | D41.8 | D49.59 |
| ureter, ureteral | C66. | C79.19 | D09.19 | D30.2 | D41.2 | D49.59 |
| urethra, urethral (gland) | C68.0 | C79.19 | D09.19 | D30.4 | D41.3 | D49.59 |
| urinary organ or system › specified sites NEC | C68.8 | C79.19 | D09.19 | D30.8 | D41.8 | D49.59 |
| utricle, prostatic | C68.0 | C79.19 | D09.19 | D30.4 | D41.3 | D49.59 |
Patient EducationClinical
Cancer
Cancer is not just one disease but many diseases. Cancer begins in your cells, which are the building blocks of your body. Usually, your body forms new cells as needed, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should.
The full article covers:
- What is cancer?
- What are the types of cancer?
- How does cancer develop?
- What are the symptoms of cancer?
- How is cancer diagnosed?
- What are the treatments for cancer?
- Can cancer be prevented?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert C79.19 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About C79.19Overview
Is C79.19 a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report secondary malignant neoplasm of other urinary organs on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does C79.19 group to?
When secondary malignant neoplasm of other urinary organs is the principal diagnosis on an inpatient stay, it groups to MS-DRG 656, 657, 658, 686, 687, 688, with relative weights from 0.7903 to 3.1838 depending on complications. Higher weights mean higher Medicare reimbursement.
What is the ICD-9 equivalent of C79.19?
Under the General Equivalence Mappings, secondary malignant neoplasm of other urinary organs converts to ICD-9-CM 198.1 (sec malig neo urin NEC). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
